Skip to main content
Sign In

About the Program

                            Thomas L. Petty Aspen Lung Conference
                                           57th Annual Meeting
                                     “Rebuildling the Injured Lung”
                                              June 4-7, 2014 
                                    The Gant
Conference Center
                                            Aspen, Colorado
The theme of the Thomas L. Petty Aspen Lung Conference, 57th Annual Meeting is “Rebuilding the Injured Lung”, David Riches, Ph.D., Chair and Ellen Burnham, M.D., Marc Moss M.D., Gregory Downey, M.D. and Eric Schmidt, M.D., Co-Chairs.  With an emphasis on the integration of basic, translational and clinical sciences, the meeting will focus on the central question how knowledge of the mechanisms of acute and chronic alveolar epithelial injury can be translated into specific approaches to reconstitute and rebuild the injured lung.  Anchored by twelve State of the Art Presentations from thought leaders in their respective fields, the conference will specifically focus on: (i) the mechanisms of acute and progressive lung injury and fibrosis,  (ii) conceptual issues centering around the complex interactions between epithelial cells, mesenchymal cells and the extracellular connective tissue matrix, (iii) harnessing contemporary understanding of matrix scaffolds and stem cell biology to therapeutically repair and rebuild the injured lung, and (iv) strategic approaches to assessing and improving therapy.  The conference summary will be presented by Peter Bitterman, M.D., University of Minnesota, Minneapolis, Minnesota.
Abstract deadline is February 14, 2014.  For more information, contact: David W.H. Riches, Ph.D., c/o Jeanne Cleary, Thomas L. Petty Aspen Lung Conference, PO Box 1622, Parker, CO 80134   Phone:  (303) 358-2797.  Fax:  (720) 851-1034. 
Program Learning Objectives
A)   Provide an international forum for leading clinicians and researchers to exchange ideas relating to lung research in the broad field of lung injury, repair, reconstruction and therapeutic outcomes.
B)    Fill knowledge gaps in the understanding of lung injury, repair and reconstruction.
C)    Stimulate new perspectives and research in pulmonary medicine in the area of the lung injury, repair and reconstruction, with significant time allowed for discussion joined by leading national and international experts in basic, translational and clinical research.
At the conclusion of this conference the attendees will be able to:
 1)     Describe the developmental basis for the lung injury, repair and reconstruction.
2)    Identify differences in the mechanisms of acute and progressive lung injury and their outcomes.
3)    Describe current understanding of the therapeutic and reconstructive approaches to the treatment of acute and progressive lung injury.
4)    Identify potential therapeutic targets, novel medications and regenerative medicine approaches that could be applied to returning the injured lung to “normal” thereby improving outcome.
5)    Be able to clearly assess and rate shared pathogenic mechanisms that underlie acute and progressive lung injury (e.g. ARDS) and fibrosis (e.g. IPF or other IIPs)
6)    Attendees, specifically junior faculty and trainees, will receive feedback on their research in progress (submitted in the form of abstracts, presented as posters and talks) that they can implement to ensure the quality, innovation, and applicability of their work. 
Intended Audience:  Local/Regional/National/International
Physicians/clinicians (adult and pediatric)/Research Physician-Scientists-Pulmonary Sciences, Critical Care and Sleep Medicine/Primary Care Physicians/General Medicine Physicians/Public Health

Americans with Disability Act statement 
Please indicate if you have any need for auxiliary aids or special assistance services:
Accreditation Statement
The University of Colorado School of Medicine is accredited by the Accreditation Council for     Continuing Medical Education to provide continuing medical education for physicians. 

The University of Colorado School of Medicine designates this live activity for a maximum of 13 AMA PRA Category 1 Credits™.   Physicians should claim only the credit commensurate with the extent of their participation in the activity.